| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Laboratory of Clinical Science, Building 10, Room 3D41, 10 Center Drive, MSC 1264, NIMH, NIH, Bethesda, MD 20892;
2 Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510;
3 Molecular and Clinical Psychobiology, Department of Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany
Correspondence: Please address all correspondence to DLM. Email murphyd{at}intra.nimh.nih.gov; fax 301-402-0188.
The highly evolutionarily conserved serotonin transporter (SERT) regulates the entire serotoninergic system and its receptors via mod-ulation of extracellular fluid serotonin concentrations. Differences in SERT expression and function produced by three SERT genes and their variants show associations with multiple human disorders. Screens of DNA from patients with autism, ADHD, bipolar disorder, and Tourette’s syndrome have detected signals in the chromosome 17q region where SERT is locat-ed. Parallel investigations of SERT knockout mice have uncovered multiple phenotypes that identify SERT as a candidate gene for additional human disorders ranging from irritable bowel syndrome to obesity. Replicated studies have demonstrated that the SERT 5'-flanking region polymorphism SS genotype is associated with poorer therapeutic responses and more frequent serious side effects during treatment with antidepressant SERT antagonists, namely, the serotonin reuptake inhibitors (SRIs).
This article has been cited by other articles:
|
|
 |
|
  J. R. Wendland, P. R. Moya, M. R. Kruse, R. F. Ren-Patterson, C. L. Jensen, K. R. Timpano, and D. L. Murphy A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder Hum. Mol. Genet., March 1, 2008; 17(5): 717 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-W. Zhang, J. Gesmonde, S. Ramamoorthy, and G. Rudnick Serotonin Transporter Phosphorylation by cGMP-Dependent Protein Kinase Is Altered by a Mutation Associated with Obsessive Compulsive Disorder J. Neurosci., October 3, 2007; 27(40): 10878 - 10886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-B. Zhu, J. A. Steiner, J. L. Munn, L. C. Daws, W. A. Hewlett, and R. D. Blakely Rapid Stimulation of Presynaptic Serotonin Transport by A3 Adenosine Receptors J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 332 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yang, K. Li, P. C. Ng, C. K. Y. Chuen, T. K. Lau, Y. S. Cheng, Y. S. Liu, C. K. Li, P. Man Pan Yuen, A. Edward James, et al. Promoting Effects of Serotonin on Hematopoiesis: Ex Vivo Expansion of Cord Blood CD34+ Stem/Progenitor Cells, Proliferation of Bone Marrow Stromal Cells, and Antiapoptosis Stem Cells, July 1, 2007; 25(7): 1800 - 1806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Muller, O. Wiborg, and J. Haase Subcellular Redistribution of the Serotonin Transporter by Secretory Carrier Membrane Protein 2 J. Biol. Chem., September 29, 2006; 281(39): 28901 - 28909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. D. Carneiro and R. D. Blakely Serotonin-, Protein Kinase C-, and Hic-5-associated Redistribution of the Platelet Serotonin Transporter J. Biol. Chem., August 25, 2006; 281(34): 24769 - 24780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-A. Enoch, P.-H. Shen, K. Xu, C. Hodgkinson, and D. Goldman Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol, July 1, 2006; 20(4 Suppl): 19 - 26. [Abstract] [PDF]
|
|
|
|
|
|
J. Kirchheiner, D. Grundemann, and E. Schomig Contribution of allelic variations in transporters to the phenotype of drug response. J Psychopharmacol, July 1, 2006; 20(4 Suppl): 27 - 32. [Abstract] [PDF]
|
|
|
|
 |
|
 H. C. Prasad, C.-B. Zhu, J. L. McCauley, D. J. Samuvel, S. Ramamoorthy, R. C. Shelton, W. A. Hewlett, J. S. Sutcliffe, and R. D. Blakely Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase PNAS, August 9, 2005; 102(32): 11545 - 11550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Jayanthi, D. J. Samuvel, R. D. Blakely, and S. Ramamoorthy Evidence for Biphasic Effects of Protein Kinase C on Serotonin Transporter Function, Endocytosis, and Phosphorylation Mol. Pharmacol., June 1, 2005; 67(6): 2077 - 2087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-B. Zhu, A. M. Carneiro, W. R. Dostmann, W. A. Hewlett, and R. D. Blakely p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process J. Biol. Chem., April 22, 2005; 280(16): 15649 - 15658. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |
